Insider Trading & Ownership of Paul L. Berns

Location
Watertown, MA
Summary
The estimated net worth of Paul L. Berns is at least $27,211,767 dollars as of 19 Feb 2026. Paul L. Berns is the Title: Chief Executive Officer and Chairman of the Board, Director of Neumora Therapeutics, Inc. and owns shares of Neumora Therapeutics, Inc. (NMRA) stock worth about $26.22M. Paul L. Berns is the Director of Jazz Pharmaceuticals plc and owns shares of Jazz Pharmaceuticals plc (JAZZ) stock worth about $987.6K.
Signature
/s/ Michael Milligan, as Attorney-in-Fact for Paul L. Berns
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Paul L. Berns and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • Paul L. Berns has 5 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $27,211,767.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Neumora Therapeutics, Inc. ($26,224,179).
  • Past-year value change for that position: -$34,459.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Paul L. Berns

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NMRA Neumora Therapeutics, Inc. Title: Chief Executive Officer and Chairman of the Board, Director $26,224,179 -$34,459 -0.13% 17 Feb 2026
JAZZ Jazz Pharmaceuticals plc Director $987,588 05 Aug 2021
MTSR Metsera, Inc. Director $0 13 Nov 2025
EQRX EQRx, Inc. Director 09 Nov 2023
UBX Unity Biotechnology, Inc. Director 21 Jun 2024

Insider Transactions Reported by Paul L. Berns:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored